With record revenues, store additions, and strong private label momentum, Baazar Style Retail ended FY25 with strong growth.
With a strong balance sheet and healthy cash flows, ROHL can undertake rapid expansion and press the growth pedal.
The company sees a surge in demand, particularly in rural areas
The company’s capability enhancement is geared for emerging tailwinds, ranging from the China +1 opportunity to the recent pricing regulation in the US.
While India business outlook is robust, DP Eurasia (mainly Turkey business) is currently facing macroeconomic challenges, owing to hyper inflation
Sustained growth with global expansion and strong market share
Luggage sector saw a difficult going in FY25, can things change for the better?
Outperforming industry growth amid challenging market conditions
The company is expected to capitalise on the growing natural gas consumption demand
The medium-term growth drivers include the global rollout of respiratory and GLP-1 drugs.
The expected easing of global and domestic uncertainties should help the company perform better
Steady ARPU lifts the company’s Q4 performance across India and Africa
Tata Steel is now focusing on capital allocation. It is undertaking capex, based on the merits of the business and the regions concerned
While the management remains confident about the business, the lack of clarity of US tariffs on the UK continues to cast a shadow.
With the equity market trading in a narrow range, MTM gain is likely to be lower and may not contribute much to the AUM growth
Calibrated product mix, post-merger synergies are key growth levers
Balanced growth across verticals; structural tailwinds from government, defence and global mobility
The new regulation appears to be less disruptive for the Indian generics; may impact those having exposure to speciality/patented portfolios
Normal monsoon, better execution expected to aid growth recovery
Even after the tariff rebalancing, the long-term case for China + 1 stays
Growth guidance intact, but core portfolio stress needs to be watched
Higher volume sales partly offset headwinds
Pharma players working on speciality/patented portfolios could be impacted more
The company continues to deliver strong top-line growth, but continued investment in Quick Commerce and rising competitive intensity are weighing on margins.
One of the company’s key growth drivers is the rising demand for premium vehicles, including big cars, SUVs, and high-end bikes, now extending to the consumer durable segment.